A detailed history of Pfg Investments, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Pfg Investments, LLC holds 334,600 shares of ADMA stock, worth $3.83 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
334,600
Previous 43,000 678.14%
Holding current value
$3.83 Million
Previous $194 Million 1036.22%
% of portfolio
0.13%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$4.4 - $6.74 $1.28 Million - $1.97 Million
291,600 Added 678.14%
334,600 $2.21 Billion
Q4 2023

Jan 17, 2024

SELL
$3.08 - $4.52 $40,040 - $58,759
-13,000 Reduced 23.21%
43,000 $194 Million
Q3 2023

Nov 06, 2023

SELL
$3.47 - $4.61 $57,255 - $76,065
-16,500 Reduced 22.76%
56,000 $200 Million
Q2 2023

Aug 03, 2023

SELL
$3.12 - $4.22 $46,800 - $63,299
-15,000 Reduced 17.14%
72,500 $268 Million
Q1 2023

May 11, 2023

BUY
$3.01 - $3.87 $263,375 - $338,625
87,500 New
87,500 $290 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $2.25B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Pfg Investments, LLC Portfolio

Follow Pfg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Investments, LLC with notifications on news.